CoChat

The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling

Open access
Cueva Vargas, Jorge L., Belforte, Nicolas, Di Polo, Adriana · 2016 · Neurobiology of Disease
Cited by 60

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide. Vision deficits in glaucoma result from the selective loss of retinal ganglion cells (RGC). Glial cell-mediated neuroinflammation has been proposed to contribute to disease pathophysiology, but whether this response is harmful or beneficial for RGC survival is not well understood. To test this, we characterized the role of ibudilast, a clinically approved cAMP phosphodiesterase (PDE) inhibitor with preferential affinity for PDE type 4 (PDE4). Here, we demonstrate that intraocular administration of ibudilast dampened macroglia and microglia reactivity in the retina and optic nerve hence decreasing production of proinflammatory cytokines in a rat model of ocular hypertension. Importantly, ibudilast promoted robust RGC soma survival, prevented axonal degeneration, and improved anterograde axonal transport in glaucomatous eyes without altering intraocular pressure. Intriguingly, ocular hypertension triggered upregulation of PDE4 subtype A in Müller glia, and ibudilast stimulated cAMP accumulation in these cells. Co-administration of ibudilast with Rp-cAMPS, a cell-permeable and non-hydrolysable cAMP analog that inhibits protein kinase A (PKA), completely blocked ibudilast-induced neuroprotection. Collectively, these data demonstrate that ibudilast, a safe and well-tolerated glial cell modulator, attenuates gliosis, decreases levels of proinflammatory mediators, and enhances neuronal viability in glaucoma through activation of the cAMP/PKA pathway. This study provides insight into PDE4 signaling as a potential target to counter the harmful effects associated with chronic gliosis and neuroinflammation in glaucoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2016.05.002

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 101

  1. Abbott, 2014, Comparison of retinal nerve fiber layer thickness in vivo and axonal transport after chronic intraocular pressure elevation in young versus older rats, PLoS ONE, 9, 10.1371/journal.pone.0114546 · DOI
  2. Ahlers, 2015, Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration, Glia, 63, 1694, 10.1002/glia.22835 · DOI · Paper page
  3. Ahmed, 2004, Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure, Invest. Ophthalmol. Vis. Sci., 45, 1247, 10.1167/iovs.03-1123 · DOI · Paper page
  4. Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat. Neurosci., 10, 1538, 10.1038/nn2014 · DOI · Paper page
  5. Almasieh, 2010, Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors, Cell Death Dis., 1, 10.1038/cddis.2009.23 · DOI · Paper page
  6. Almasieh, 2013, Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma, Invest. Ophthalmol. Vis. Sci., 54, 3171, 10.1167/iovs.12-11481 · DOI
  7. Angelucci, 1996, Anterograde axonal tracing with the subunit B of cholera toxin: a highly sensitive immunohistochemical protocol for revealing fine axonal morphology in adult and neonatal brains, J. Neurosci. Methods, 65, 101, 10.1016/0165-0270(95)00155-7 · DOI · Paper page
  8. Atkins, 2007, Modulation of the cAMP signaling pathway after traumatic brain injury, Exp. Neurol., 208, 145, 10.1016/j.expneurol.2007.08.011 · DOI
  9. Ba, 2015, Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis, Drug Des. Devel. Ther., 9, 5397
  10. Bacher, 2010, The role of macrophage migration inhibitory factor in Alzheimer's disease, Mol. Med., 16, 116, 10.2119/molmed.2009.00123 · DOI · Paper page
  11. Bausher, 1995, Regulation of cyclic AMP production in adult human ciliary processes, Exp. Eye Res., 60, 43, 10.1016/S0014-4835(05)80082-X · DOI
  12. Bode, 1993, Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium, J. Pharmacol. Exp. Ther., 267, 1286, 10.1016/S0022-3565(25)39578-9 · doi:10.1016/s0022-3565(25)39578-9
  13. Bosco, 2011, Early microglia activation in a mouse model of chronic glaucoma, J. Comp. Neurol., 519, 599, 10.1002/cne.22516 · DOI · Paper page
  14. Bosco, 2012, Early reduction of microglia activation by irradiation in a model of chronic glaucoma, PLoS ONE, 7, 10.1371/journal.pone.0043602 · DOI · Paper page
  15. Cen, 2015, Bilateral retinal microglial response to unilateral optic nerve transection in rats, Neuroscience, 311, 56, 10.1016/j.neuroscience.2015.09.067 · DOI
  16. Charbonneau, 1986, Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species, Proc. Natl. Acad. Sci. U. S. A., 83, 9308, 10.1073/pnas.83.24.9308 · doi:10.1073/pnas.83.24.9308
  17. Chidlow, 2012, Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells, Neurobiol. Dis., 48, 568, 10.1016/j.nbd.2012.07.026 · DOI · Paper page
  18. Chong, 2015, Glial cell interactions and glaucoma, Curr. Opin. Ophthalmol., 26, 73, 10.1097/ICU.0000000000000125 · DOI · Paper page
  19. Corredor, 2012, Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth, J. Neurosci., 32, 7734, 10.1523/JNEUROSCI.5288-11.2012 · DOI
  20. Cui, 2003, Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons, Mol. Cell. Neurosci., 22, 49, 10.1016/S1044-7431(02)00037-4 · DOI · Paper page
  21. Dal Piaz, 2000, Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies, Eur. J. Med. Chem., 35, 463, 10.1016/S0223-5234(00)00179-3 · DOI
  22. Dengler-Crish, 2014, Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma, Front. Neurosci., 8, 290, 10.3389/fnins.2014.00290 · DOI · Paper page
  23. Dostmann, 1995, (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition, FEBS Lett., 375, 231, 10.1016/0014-5793(95)01201-O · DOI
  24. Ebneter, 2010, Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury, Invest. Ophthalmol. Vis. Sci., 51, 6448, 10.1167/iovs.10-5284 · DOI · Paper page
  25. Firth, 2005, Retinal waves: mechanisms and function in visual system development, Cell Calcium, 37, 425, 10.1016/j.ceca.2005.01.010 · DOI
  26. Fujino, 2009, Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-alpha-induced optic nerve degeneration, Acta Neuropathol., 117, 75, 10.1007/s00401-008-0440-9 · DOI
  27. Galindo-Romero, 2013, Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia, Invest. Ophthalmol. Vis. Sci., 54, 974, 10.1167/iovs.12-11207 · DOI
  28. Gerlo, 2011, Cyclic AMP: a selective modulator of NF-kappaB action, Cell. Mol. Life Sci., 68, 3823, 10.1007/s00018-011-0757-8 · DOI · Paper page
  29. Gibson, 2006, The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family, Eur. J. Pharmacol., 538, 39, 10.1016/j.ejphar.2006.02.053 · DOI
  30. Goldberg, 2002, Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity, Neuron, 33, 689, 10.1016/S0896-6273(02)00602-5 · DOI · Paper page
  31. Gramlich, 2013, Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina, PLoS ONE, 8, 10.1371/journal.pone.0057557 · DOI · Paper page
  32. Hernandez, 2008, Astrocytes in glaucomatous optic neuropathy, Prog. Brain Res., 173, 353, 10.1016/S0079-6123(08)01125-4 · DOI · Paper page
  33. Houslay, 2010, Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown, Trends Biochem. Sci., 35, 91, 10.1016/j.tibs.2009.09.007 · DOI · Paper page
  34. Houslay, 2005, Keynote review: phosphodiesterase-4 as a therapeutic target, Drug Discov. Today, 10, 1503, 10.1016/S1359-6446(05)03622-6 · DOI · Paper page
  35. Howell, 2012, Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma, J. Clin. Invest., 122, 1246, 10.1172/JCI61135 · DOI · Paper page
  36. Huang, 2006, Preferential inhibition of human phosphodiesterase 4 by ibudilast, Life Sci., 78, 2663, 10.1016/j.lfs.2005.10.026 · DOI
  37. Inacio, 2011, Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke, J. Cereb. Blood Flow Metab., 31, 1093, 10.1038/jcbfm.2010.194 · DOI · Paper page
  38. Inman, 2007, Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma, Glia, 55, 942, 10.1002/glia.20516 · DOI · Paper page
  39. Inoue, 2008, Effect of ibudilast on non-specific symptoms in patients with chronic cerebral ischemia, Arzneimittelforschung, 58, 277
  40. Iona, 1998, Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain, Mol. Pharmacol., 53, 23, 10.1124/mol.53.1.23 · DOI
  41. Johnson, 2009, Friend or foe?Resolving the impact of glial responses in glaucoma, J. Glaucoma, 18, 341, 10.1097/IJG.0b013e31818c6ef6 · DOI · Paper page
  42. Kuehn, 2008, Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion, Exp. Eye Res., 87, 89, 10.1016/j.exer.2008.04.012 · DOI
  43. Lebrun-Julien, 2009, Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism, J. Neurosci., 29, 5536, 10.1523/JNEUROSCI.0831-09.2009 · DOI · Paper page
  44. Lebrun-Julien, 2009, Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells, Mol. Cell. Neurosci., 40, 410, 10.1016/j.mcn.2008.12.005 · DOI
  45. Lebrun-Julien, 2010, ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway, Proc. Natl. Acad. Sci. U. S. A., 107, 3817, 10.1073/pnas.0909276107 · DOI · Paper page
  46. Lee, 2014, Control of outflow resistance by soluble adenylyl cyclase, J. Ocul. Pharmacol. Ther., 30, 138, 10.1089/jop.2013.0199 · DOI
  47. Leibinger, 2013, Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation, Cell Death Dis., 4, 10.1038/cddis.2013.126 · DOI
  48. Li, 2003, Axon regeneration in goldfish and rat retinal ganglion cells: differential responsiveness to carbohydrates and cAMP, J. Neurosci., 23, 7830, 10.1523/JNEUROSCI.23-21-07830.2003 · doi:10.1523/jneurosci.23-21-07830.2003
  49. Mali, 2011, A decrease in phosphorylation of cAMP-response element-binding protein (CREBP) promotes retinal degeneration, Exp. Eye Res., 92, 528, 10.1016/j.exer.2011.03.017 · DOI
  50. Matsuda, 1997, Expression of macrophage migration inhibitory factor in rat retina and its immunohistochemical localization, J. Neuroimmunol., 77, 85, 10.1016/S0165-5728(97)00061-1 · DOI
  51. Mehats, 2002, Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling, Trends Endocrinol. Metab., 13, 29, 10.1016/S1043-2760(01)00523-9 · DOI · Paper page
  52. Mizuno, 2004, Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia, Neuropharmacol., 46, 404, 10.1016/j.neuropharm.2003.09.009 · DOI · Paper page
  53. Morrison, 1997, A rat model of chronic pressure-induced optic nerve damage, Exp. Eye Res., 64, 85, 10.1006/exer.1996.0184 · DOI · Paper page
  54. Morrison, 2015, Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure, Exp. Eye Res., 141, 23, 10.1016/j.exer.2015.05.012 · DOI
  55. Nakazawa, 2006, Tumor necrosis factor-{alpha} mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma, J. Neurosci., 26, 12633, 10.1523/JNEUROSCI.2801-06.2006 · DOI · Paper page
  56. Nathanson, 1980, Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium, Proc. Natl. Acad. Sci. U. S. A., 77, 7420, 10.1073/pnas.77.12.7420 · doi:10.1073/pnas.77.12.7420
  57. Noguchi, 2009, Vasodilator effects of ibudilast on retinal blood vessels in anesthetized rats, Biol. Pharm. Bull., 32, 1924, 10.1248/bpb.32.1924 · doi:10.1248/bpb.32.1924
  58. Park, 2015, AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells, Exp. Eye Res., 132, 136, 10.1016/j.exer.2015.01.026 · DOI
  59. Paterniti, 2014, Phosphodiesterase as a new therapeutic target for the treatment of spinal cord injury and neurodegenerative diseases, Curr. Med. Chem., 21, 2830, 10.2174/0929867321666140217102428 · doi:10.2174/0929867321666140217102428
  60. Pearce, 2015, Advances in drug delivery to the posterior segment, Curr. Opin. Ophthalmol., 26, 233, 10.1097/ICU.0000000000000143 · DOI
  61. Pearse, 2004, cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury, Nat. Med., 10, 610, 10.1038/nm1056 · DOI · Paper page
  62. Penfold, 1991, Antibodies to human leucocyte antigens indicate subpopulations of microglia in human retina, Vis. Neurosci., 7, 383, 10.1017/S0952523800004879 · DOI · Paper page
  63. Popp, 2009, Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease, J. Psychiatr. Res., 43, 749, 10.1016/j.jpsychires.2008.10.006 · DOI
  64. Poulsen, 2014, Primary culture of trigeminal satellite glial cells: a cell-based platform to study morphology and function of peripheral glia, Int. J. Physiol. Pathophysiol. Pharmacol., 6, 1
  65. Prinz, 2011, Microglia in the CNS: immigrants from another world, Glia, 59, 177, 10.1002/glia.21104 · DOI · Paper page
  66. Reichenbach, 2013, New functions of Müller cells, Glia, 61, 651, 10.1002/glia.22477 · DOI · Paper page
  67. Ren, 2010, A role for complement in glaucoma?, Adv. Exp. Med. Biol., 703, 95, 10.1007/978-1-4419-5635-4_7 · DOI
  68. Rodgers, 2014, Reversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppression, J. Neurotrauma, 31, 487, 10.1089/neu.2013.3090 · DOI
  69. Rojas, 2014, Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers, J. Neuroinflammation, 11, 133, 10.1186/1742-2094-11-133 · DOI · Paper page
  70. Rolan, 2009, Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease, Expert. Opin. Pharmacother., 10, 2897, 10.1517/14656560903426189 · DOI · Paper page
  71. Ruzafa, 2015, Effect of Müller cells on the survival and neuritogenesis in retinal ganglion cells, Arch Soc Esp Oftalmol., 90, 522, 10.1016/j.oftal.2015.03.009 · doi:10.1016/j.oftal.2015.03.009
  72. Sachs, 2007, Regulation of cAMP by the p75 neurotrophin receptor: insight into drug design of selective phosphodiesterase inhibitors, Biochem. Soc. Trans., 35, 1273, 10.1042/BST0351273 · DOI
  73. Sanchez, 2003, Interleukin-6 in retinal ischemia reperfusion injury in rats, Invest. Ophthalmol. Vis. Sci., 44, 4006, 10.1167/iovs.03-0040 · DOI · Paper page
  74. Schaal, 2012, The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury, PLoS ONE, 7, 10.1371/journal.pone.0043634 · DOI
  75. Schwartz, 2008, Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation, Prog. Brain Res., 173, 375, 10.1016/S0079-6123(08)01126-6 · DOI
  76. Schwartz, 2009, Immune maintenance in glaucoma: boosting the body's own neuroprotective potential, J. Ocul. Biol. Dis. Infor., 2, 73, 10.1007/s12177-009-9025-7 · DOI
  77. Scott, 1991, Cyclic nucleotide-dependent protein kinases, Pharmacol. Ther., 50, 123, 10.1016/0163-7258(91)90075-W · DOI · Paper page
  78. Stasi, 2006, Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes, Invest. Ophthalmol. Vis. Sci., 47, 1024, 10.1167/iovs.05-0830 · DOI · Paper page
  79. Stellwagen, 1999, Dynamics of retinal waves are controlled by cyclic AMP, Neuron, 24, 673, 10.1016/S0896-6273(00)81121-6 · DOI · Paper page
  80. Stevens, 2007, The classical complement cascade mediates CNS synapse elimination, Cell, 131, 1164, 10.1016/j.cell.2007.10.036 · DOI · Paper page
  81. Stewart, 2015, The clinical utility of aflibercept for diabetic macular edema, Diabetes Metab. Syndr. Obes., 8, 473, 10.2147/DMSO.S72792 · DOI
  82. Sun, 2013, Reversible reactivity by optic nerve astrocytes, Glia, 61, 1218, 10.1002/glia.22507 · DOI · Paper page
  83. Suzumura, 1999, Ibudilast suppresses TNF-alpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS, Brain Res., 837, 203, 10.1016/S0006-8993(99)01666-2 · DOI
  84. Tezel, 2013, Immune regulation toward immunomodulation for neuroprotection in glaucoma, Curr. Opin. Pharmacol., 13, 23, 10.1016/j.coph.2012.09.013 · DOI
  85. Tezel, 2004, Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice, Brain Res., 996, 202, 10.1016/j.brainres.2003.10.029 · DOI · Paper page
  86. Tezel, 2010, Oxidative stress and the regulation of complement activation in human glaucoma, Invest. Ophthalmol. Vis. Sci., 51, 5071, 10.1167/iovs.10-5289 · DOI · Paper page
  87. Tezel, 2012, An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma, Invest. Ophthalmol. Vis. Sci., 53, 4220, 10.1167/iovs.11-9101 · DOI · Paper page
  88. Travaglione, 2002, Epithelial cells and expression of the phagocytic marker CD68: scavenging of apoptotic bodies following rho activation, Toxicol. in Vitro, 16, 405, 10.1016/S0887-2333(02)00028-0 · DOI
  89. Vecino, 2016, Glia–neuron interactions in the mammalian retina, Prog Ret Eye Res., 51, 1, 10.1016/j.preteyeres.2015.06.003 · DOI · Paper page
  90. Wang, 2002, Immunohistologic evidence for retinal glial cell changes in human glaucoma, Invest. Ophthalmol. Vis. Sci., 43, 1088
  91. Wang, 2014, Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina, J. Neurosci., 34, 3793, 10.1523/JNEUROSCI.3153-13.2014 · DOI · Paper page
  92. Watanabe, 2003, Intravitreal injections of neurotrophic factors and forskolin enhance survival and axonal regeneration of axotomized beta ganglion cells in cat retina, Neuroscience, 116, 733, 10.1016/S0306-4522(02)00562-6 · DOI
  93. Weinreb, 2004, Primary open-angle glaucoma, Lancet, 363, 1711, 10.1016/S0140-6736(04)16257-0 · DOI · Paper page
  94. Whitaker, 2009, The novel distribution of phosphodiesterase-4 subtypes within the rat retina, Neuroscience, 163, 1277, 10.1016/j.neuroscience.2009.07.045 · DOI
  95. Wilson, 2015, Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma, J. Neuroinflammation, 12, 176, 10.1186/s12974-015-0399-0 · DOI
  96. Wohl, 2010, Proliferative response of microglia and macrophages in the adult mouse eye after optic nerve lesion, Invest. Ophthalmol. Vis. Sci., 51, 2686, 10.1167/iovs.09-4537 · DOI
  97. Yang, 2011, Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina, Invest. Ophthalmol. Vis. Sci., 52, 8442, 10.1167/iovs.11-8152 · DOI · Paper page
  98. Yoshioka, 1998, Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity, J. Neurochem., 70, 2416, 10.1046/j.1471-4159.1998.70062416.x · DOI
  99. Yuan, 2001, Activated microglia in the human glaucomatous optic nerve head, J. Neurosci. Res., 64, 523, 10.1002/jnr.1104 · DOI · Paper page
  100. Zhou, 2005, Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma, Mol. Ther., 12, 402, 10.1016/j.ymthe.2005.04.004 · DOI · Paper page
  101. Zhu, 2001, The antidepressant and antiinflammatory effects of rolipram in the central nervous system, CNS Drug Rev., 7, 387, 10.1111/j.1527-3458.2001.tb00206.x · DOI · Paper page

Cited by

See all 60

Metadata

Authors
Cueva Vargas, J. L., Belforte, N., & Di Polo, A.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2016-09
Volume
93
Pages
156-171
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2369799003
Cited by
60
References
10
FWCI
4.45
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Canadian Institutes of Health Research (CIHR-VIH-105439)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. https://app.cochat.ai/papers/10.1016/j.nbd.2016.05.002
The paper
Cueva Vargas, J. L., Belforte, N., & Di Polo, A. (2016). The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2016.05.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.